ArticleAdvances in therapy2024

Treatment Outcomes with Standard of Care in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Real-World Data Analysis.

Andrew Ip et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.